An RCT that investigated the effect of ghrelin in patients receiving chemotherapy for esophageal cancer that included cisplatin found that ghrelin resulted in more food intake, prevented a decline in prealbumin and transferrin levels, and was associated with significantly fewer adverse events involving anorexia and nausea [66]. The gene discussed is GHRL; the disease is esophageal cancer.